Targeting the role of the endosome in the pathophysiology of Alzheimer's disease: a strategy for treatment
- PMID: 16807486
- DOI: 10.1126/sageke.2006.10.re2
Targeting the role of the endosome in the pathophysiology of Alzheimer's disease: a strategy for treatment
Abstract
Membrane-bound endosomal vesicles play an integral role in multiple cellular events, including protein processing and turnover, and often critically regulate the cell-surface availability of receptors and other plasma membrane proteins in many different cell types. Neurons are no exception, being dependent on endosomal function for housekeeping and synaptic events. Growing evidence suggests a link between neuronal endosomal function and Alzheimer's disease (AD) pathophysiology. Endosomal abnormalities invariably occur within neurons in AD brains, and endocytic compartments are one likely site for the production of the pathogenic beta-amyloid peptide (Abeta), which accumulates within the brain during the disease and is generated by proteolytic processing of the amyloid precursor protein (APP). The enzymes and events involved in APP processing are appealing targets for therapeutic agents aimed at slowing or reversing the pathogenesis of AD. The neuronal endosome may well prove to be the intracellular site of action for inhibitors of beta-amyloidogenic APP processing. We present here the view that knowledge of the endosomal system in the disease can guide drug discovery of AD therapeutic agents.
Similar articles
-
Structure and functions of the human amyloid precursor protein: the whole is more than the sum of its parts.Prog Neurobiol. 2007 May;82(1):11-32. doi: 10.1016/j.pneurobio.2007.02.001. Epub 2007 Feb 13. Prog Neurobiol. 2007. PMID: 17428603 Review.
-
Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases.Neurobiol Aging. 2005 Mar;26(3):373-82. doi: 10.1016/j.neurobiolaging.2004.09.018. Neurobiol Aging. 2005. PMID: 15639316 Review.
-
Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome.Neurobiol Aging. 2004 Nov-Dec;25(10):1263-72. doi: 10.1016/j.neurobiolaging.2004.02.027. Neurobiol Aging. 2004. PMID: 15465622 Clinical Trial.
-
The role of amyloid beta peptide 42 in Alzheimer's disease.Pharmacol Ther. 2007 Nov;116(2):266-86. doi: 10.1016/j.pharmthera.2007.06.006. Epub 2007 Jul 17. Pharmacol Ther. 2007. PMID: 17716740 Review.
-
LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease.Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17967-72. doi: 10.1073/pnas.0605461103. Epub 2006 Nov 10. Proc Natl Acad Sci U S A. 2006. PMID: 17098871 Free PMC article.
Cited by
-
Role of endolysosomes and cholesterol in the pathogenesis of Alzheimer's disease: Insights into why statins might not provide clinical benefit.Austin J Pharmacol Ther. 2014 Aug 26;2(6):1035. Austin J Pharmacol Ther. 2014. PMID: 25859562 Free PMC article.
-
Neuronal protein trafficking associated with Alzheimer disease: from APP and BACE1 to glutamate receptors.Cell Adh Migr. 2009 Jan-Mar;3(1):118-28. doi: 10.4161/cam.3.1.7254. Epub 2009 Jan 21. Cell Adh Migr. 2009. PMID: 19372755 Free PMC article. Review.
-
Mitochondrial Alterations in Neurons Derived from the Murine AppNL-F Knock-In Model of Alzheimer's Disease.J Alzheimers Dis. 2022;90(2):565-583. doi: 10.3233/JAD-220383. J Alzheimers Dis. 2022. PMID: 36155507 Free PMC article.
-
Insights of Endocytosis Signaling in Health and Disease.Int J Mol Sci. 2023 Feb 3;24(3):2971. doi: 10.3390/ijms24032971. Int J Mol Sci. 2023. PMID: 36769293 Free PMC article. Review.
-
The early endosome: a busy sorting station for proteins at the crossroads.Histol Histopathol. 2010 Jan;25(1):99-112. doi: 10.14670/HH-25.99. Histol Histopathol. 2010. PMID: 19924646 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical